ORLANDO, Fla., July 20, 2018 /PRNewswire/ -- Health Execs, physicians and diplomats were awed by the new medical devices presented by three Taiwanese companies that will enhance surgeon skills, accurately detect thyroid cancer and relieve patient bed sores. "Taiwan Medical Marvels" was the theme of this international press conference and products launch held at the Orange County Convention Center in Orlando during the Florida International Medical Expo (FIME), one of the largest medical trade shows in North America.
Dr. Min-Liang Wang, inventor and CEO of Taiwan Main Orthopedics Co., Ltd., introduced a type of smart surgical glasses befittingly named Caduceus, using revolutionary technology which combines mixed reality with surgical navigation. Caduceus allows surgeons to see through a patient's body and visualize a 3D model of the anatomy of the patient's organs. Surgeons can see the exact position of the needle insertion without ever removing their eyes off of the patient to look at any other instrumentation.
"These glasses can be thought of as X-ray glasses," said Dr. Wang, who is also an Assistant Professor in the school of Electrical and Computing Engineering at Taiwan's National Chung Cheng University. Wearing the glasses during his presentation, he explained why the response to his invention has been so overwhelming.
Ad Statistics
Times Displayed: 123641
Times Visited: 7184 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
"This technology comes from real clinical trials. Surgeons really need the advanced technology, especially during complicated surgeries like spinal surgery. Caduceus allows the surgical time to be shortened and the radiation exposure to be diminished, which benefits the patients and the physicians," he said. According to Dr. Wang, Caduceus surgical smart glasses will be available in January of 2019.
AmCad BioMed also introduced the audience to another medical technique to increase the diagnostic acumen of medical professionals regarding thyroid nodules. AmCAD-UT® Detection is the world's first Ultrasound CAD developed to accurately detect thyroid cancer, one of most common cancers in the U.S., according to the National Cancer Institute.
According to presenter James Lee, Vice President of AmCad BioMed, this new screening and imaging tool increases the quantification and visualization of the characteristics of thyroid nodules. By doing this non-invasive technique, it helps in the accurate detection and differentiation of thyroid nodules.
Patients undergoing AmCAD-UT® Detection had significantly lower screening recall rates, fifty percent less need for FNA and thirty percent less thyroidectomies.
